Some factors contributing to apoptosis dysregulation in breast cancer include p53 mutation, over expression of HER2, activation of the PI3K/AKT/mTOR pathway and overexpression of anti-apoptotic proteins such as r B-cell leukemia/lymphoma 2 (Bcl-2) [35,36]. This evidence concerns the gene ERBB2 and breast cancer.